3Shu Zheng Xi-Yong Liu Qi Dong,Cancer Institute,Zhejiang University,88 Jiefang Road,HangZhou 310009,Zhejiang Province,China Ke-feng Ding Lin-Bo Wang Pei-Lin Qiu Su-Zhan Zhang,The 2~(nd)affiliated Hospital,Medical School of Zhejiang University,88 Jiefang Road,HangZhou 310009,Zhejiang Province,China Xin-Feng Ding Yong-Zhou Shen Gao-Fei Shen Oi-Rong Sun Wei-Dong Li,Haining Cancer Institute,Haining 314400,Zhejiang Province,China.Reduction of the incidence and mortality of rectal cancer bypolypectomy:a prospective cohort study in Haining County[J].World Journal of Gastroenterology,2002,8(3):488-492. 被引量：38
4Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science, 2002,295:683-686.
5Higashi H, Tsutsumi R, Fujita A, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA,2002,99:14428-14433.
6Segal ED, Cha J, Lo J, et al. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA, 1999, 96: 14559-14564.
7Stein M, Bagnoli F, Halenbeck R, et al. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol, 2002,43:971-980.
8Backert S, Moese S, Selbach M, et al. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol, 2001,42: 631-644.
9Covacci A, Telford JL, del Giudice G, et al. Helicobacter pylori virulence and genetic geography. Science, 1999,284: 1328-1333.
10Alm RA, Ling LS, Moir DT, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature, 1999,397: 176-180.
6Bodaghi S, Yamanegi K, Xiao SY, et al. Colorectal papillomavirus in-fection in patients with colorectal cancer[ J]. Clin Cancer Res, 2005,11(8) :2862-2867.
7Elgui de Oliveira D. DNA viruses in human cancer: an integrated over-view on fundamental mechanisms of viral carcinogenesis [ J]. CancerLett, 2007,247(2):182- 196.
9Kroegel C, Reissig A. Principle mechanisms underly- ing venous thromboembolism: epidemiology, risk fac- tors, pathophysiology and pathogenesis [J]. Respira- tion, 2003,70(1) :7-30.
10Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: american college of chest physicians evidence based clinical prac- tice guidelines (8th edition) [J]. Chest,2008,133(6): 454-545.
